Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Aroda VR, Rosenstock J, Wysham C et al (2016) Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: the LixiLan-L randomized trial
Yes, SGLT2 inhibitors (such as dapagliflozin or empagliflozin) are known to increase genital yeast infection risk due to increased glucose in urine
Research suggests the route of delivery matters less than consistent dosing
All patient-outcome figures referenced here come directly from Telos Rx's own website
US$ 22.80
US$ 26.64
US$ 29.65
US$ 22.41
US$ 29.32
US$ 25.84
